IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
James S. McElvain
Advertisement
Articles by James S. McElvain
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
Advertisement
Latest Updated Articles
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)Published: October 2nd 2012 | Updated:
- GMPs for Small-Molecule Drugs in Early Development (Part I)
Published: June 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
